
NewLimitrevenue
United StatesFounded 2022
NewLimit is a biotechnology company that focuses on extending human healthspan through epigenetic reprogramming of cells. The company develops innovative medicines to restore youthful function in old cells.
NewLimit revenue
NewLimit has not published its revenue. Growjo puts it at about $4.6M a year (September 2025).
$0
$2M
$4M
$0
–
$4.6M
20222023–242025
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $4.6MEST | Growjo estimate |
NewLimit employees
NewLimit has 40 employees (September 2025, LinkedIn).
0
10
20
30
40
40
2025
NewLimit FAQ
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun NewLimit? Join the podcast